Nottingham pharma firm makes £4.1m German swoop
Nottingham-based Oncimmune Holdings, the company which provides services for the screening, detection and care of cancer, has bought German firm Protagen Diagnostics for £4.1m.
Protagen develops precision medicine and patient stratification tools for pharmaceutical multinationals in both immuno-oncology and autoimmune disease. These tools support drug development, improve treatment strategies and patient management.
QIAGEN has been involved with Protagen as an investor in the past and will continue to be an investor in Oncimmun... For the full story register now for free or login below...